{"id":225155,"date":"2026-09-01T10:06:18","date_gmt":"2026-09-01T04:36:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=225155"},"modified":"2026-09-01T10:06:18","modified_gmt":"2026-09-01T04:36:18","slug":"why-dr-lal-pathlabs-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/","title":{"rendered":"Dr. Lal Pathlabs (LALPATHLAB) Share Price Falls 2.51% Today"},"content":{"rendered":"<p style=\"margin-top:0!important;\">Dr. Lal Pathlabs Share Price fell to Rs 1,891.25 on 01 September 2026, down 2.51% for the day, taking the company\u2019s market capitalisation to Rs 32,406.57 crore. The Large Cap healthcare stock opened at Rs 1,923.45 and moved to an intraday low of Rs 1,876 before recovering part of the decline.<\/p>\n<p>Today\u2019s move has brought the stock into focus because the supplied data confirms a same-day decline from the previous close of Rs 1,939.95, with turnover at Rs 0.30 crore. The dataset establishes the price event, but it does not establish a company-specific reason for why the stock is falling today. That makes the discussion more about verified price action, valuation and sector positioning than about speculation.<\/p>\n<p>For investors tracking Dr. Lal Pathlabs Share Price, the immediate questions are clear: how weak was the intraday move, what do the available indicators suggest, how demanding is the valuation, and how does the company compare with peers in Hospital &amp; Healthcare Services. This analysis addresses those points using only the supplied numbers.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Dr_Lal_Pathlabs_LALPATHLAB_Share_Price_Today_Price_Action_Analysis\" title=\"Dr. Lal Pathlabs (LALPATHLAB) Share Price Today: Price Action Analysis\">Dr. Lal Pathlabs (LALPATHLAB) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Dr_Lal_Pathlabs_LALPATHLAB_Fundamental_Analysis\" title=\"Dr. Lal Pathlabs (LALPATHLAB) Fundamental Analysis\">Dr. Lal Pathlabs (LALPATHLAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Dr_Lal_Pathlabs\" title=\"Why Investors Are Watching Dr. Lal Pathlabs\">Why Investors Are Watching Dr. Lal Pathlabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#About_Dr_Lal_Pathlabs\" title=\"About Dr. Lal Pathlabs\">About Dr. Lal Pathlabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Track_Dr_Lal_Pathlabs_Share_Price_on_Univest\" title=\"Track Dr. Lal Pathlabs Share Price on Univest\">Track Dr. Lal Pathlabs Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Why_is_Dr_Lal_Pathlabs_Share_Price_falling_today\" title=\"Why is Dr. Lal Pathlabs Share Price falling today?\">Why is Dr. Lal Pathlabs Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#What_is_the_current_Dr_Lal_Pathlabs_Share_Price_Today\" title=\"What is the current Dr. Lal Pathlabs Share Price Today?\">What is the current Dr. Lal Pathlabs Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#How_much_did_Dr_Lal_Pathlabs_stock_fall_today\" title=\"How much did Dr. Lal Pathlabs stock fall today?\">How much did Dr. Lal Pathlabs stock fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#What_do_the_valuation_ratios_say_about_Dr_Lal_Pathlabs\" title=\"What do the valuation ratios say about Dr. Lal Pathlabs?\">What do the valuation ratios say about Dr. Lal Pathlabs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#How_profitable_is_Dr_Lal_Pathlabs_compared_with_its_industry\" title=\"How profitable is Dr. Lal Pathlabs compared with its industry?\">How profitable is Dr. Lal Pathlabs compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#How_does_Dr_Lal_Pathlabs_compare_with_Apollo_Hospitals\" title=\"How does Dr. Lal Pathlabs compare with Apollo Hospitals?\">How does Dr. Lal Pathlabs compare with Apollo Hospitals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-share-price-fall-today-2026\/#Which_sector_does_Dr_Lal_Pathlabs_belong_to\" title=\"Which sector does Dr. Lal Pathlabs belong to?\">Which sector does Dr. Lal Pathlabs belong to?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_LALPATHLAB_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Dr. Lal Pathlabs (LALPATHLAB) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,891.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,939.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 48.70 (-2.51%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,923.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,934.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,876<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.3 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,406.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock was down Rs 48.70 from the previous close of Rs 1,939.95. It opened at Rs 1,923.45, touched an intraday high of Rs 1,934.80 and then fell to Rs 1,876. This range shows that pressure emerged early and pushed the stock well below the prior close during the session.<\/p>\n<p>Even so, the current price remained above the day\u2019s low, indicating that some of the intraday weakness was pared back. Turnover stood at Rs 0.30 crore. Since no verified catalyst is available in the supplied data, the most defensible reading is that today\u2019s move is a clear price decline without an established headline trigger.<\/p>\n<p>From a technical context, the stock is also trading close to an important medium-term reference point. The 50-day moving average is Rs 1,894.01, almost in line with the current price of Rs 1,891.25, while the 200-day moving average is much lower at Rs 1,586.05. That means the stock is slightly below its 50-DMA but still comfortably above its 200-DMA. The RSI is 55.44, which does not suggest an extreme reading on the supplied numbers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_LALPATHLAB_Fundamental_Analysis\"><\/span><strong>Dr. Lal Pathlabs (LALPATHLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,406.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">60.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32.29<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 155.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.06%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The company remains a profitable large-cap healthcare business, but it trades at premium valuation multiples. Market capitalisation stands at Rs 32,406.57 crore, P\/E at 60.09 and P\/B at 12.46. EPS is Rs 32.29, book value per share is Rs 155.67 and dividend yield is 1.06%.<\/p>\n<p>Profitability is a key support point in the numbers. ROE is 22.37% and ROCE is 29.56%, both of which indicate strong capital efficiency on the supplied data. In simple terms, the company is generating relatively strong returns on shareholder equity and capital employed, which helps explain why investors assign it a higher multiple than many industry participants.<\/p>\n<p>At the same time, premium valuation can leave a stock more sensitive to shifts in sentiment. That does not explain today\u2019s decline on its own, but it does help frame why even a moderate price move can attract attention. The fundamental picture, therefore, is not one of weak returns; it is one of strong profitability paired with relatively demanding valuation ratios.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Hospital &amp; Healthcare Services<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">60.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">103.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.74x to 1,515.36x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32,406.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 742.29 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 12,193.75 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The same-industry benchmark covers 62 companies in Hospital &amp; Healthcare Services. Within that set, the company\u2019s P\/E of 60.09 is above the median of 47.88 but below the average of 103.86 across 55 companies with available P\/E data. The industry range is wide, from 7.74 to 1,515.36, which shows how dispersed valuations are in this segment.<\/p>\n<p>On price-to-book, the company stands at 12.46 versus an industry median of 4.17 and average of 4.72, placing it at a clear premium. Profitability, however, looks stronger than benchmark norms. ROE of 22.37% is well above the median of 12.82% and average of 13.8%, while ROCE of 29.56% is higher than the median of 15.7% and the average of 3.09%.<\/p>\n<p>Scale also matters in sector interpretation. At Rs 32,406.57 crore, the company is far larger than the industry median market cap of Rs 742.29 crore and above the average of Rs 12,193.75 crore. So the sector picture is fairly balanced: the stock trades at a premium to typical peers on valuation, but the business also posts stronger returns than the broader industry sample.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Apollo Hospitals Enterprise<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APOLLOHOSP<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,27,187.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">60.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.73<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/manipalhos\/manipal-health-enterpri-l-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>MANIPAL HEALTH ENTERPRI L<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MANIPALHOS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,01,527.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">112.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Max Healthcare Institute<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MAXHEALTH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">98,597.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">68.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Fortis Healthcare<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FORTIS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">70,211.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">65.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.07<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/asterdm\/aster-dm-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aster DM Healthcare<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTERDM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">64,952.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">206.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.46<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Against major listed peers, the stock looks relatively balanced on earnings valuation but stronger than several names on return ratios. Compared with Apollo Hospitals Enterprise, it trades at a near-identical P\/E of 60.09 versus 60.97 and a slightly lower P\/B of 12.46 versus 13.15. Apollo\u2019s ROE of 23.54% is marginally higher, but the company\u2019s ROCE of 29.56% is above Apollo\u2019s 21.73%.<\/p>\n<p>Versus Max Healthcare, Fortis Healthcare and Manipal Health, its P\/E is lower than all three. Its ROE and ROCE are also stronger than those three peers on the supplied data. Aster DM Healthcare stands out as a much more expensive peer on earnings, with a P\/E of 206.73 and P\/B of 13.26 despite lower ROE of 9.32% and ROCE of 11.46%.<\/p>\n<p>On market capitalisation, the company at Rs 32,406.57 crore is smaller than Apollo, Manipal, Max, Fortis and Aster in this peer set, but it is close to Krishna Institute of Medical Sciences at Rs 32,332.10 crore in the broader benchmark list. Taken together, the peer data suggests the valuation is not unusual for a premium healthcare name on P\/E, though the P\/B multiple remains elevated.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Dr_Lal_Pathlabs\"><\/span><strong>Why Investors Are Watching Dr. Lal Pathlabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock fell 2.51% to Rs 1,891.25 from the previous close of Rs 1,939.95.<\/li>\n<li>The current price is slightly below the 50-day moving average of Rs 1,894.01, but well above the 200-day moving average of Rs 1,586.05.<\/li>\n<li>P\/E at 60.09 and P\/B at 12.46 keep valuation in focus after any price decline.<\/li>\n<li>ROE of 22.37% and ROCE of 29.56% remain stronger than industry median profitability levels.<\/li>\n<li>The company operates in a premium-valued Healthcare industry where peer comparisons matter.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Dr_Lal_Pathlabs\"><\/span><strong>About Dr. Lal Pathlabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Lal Pathlabs operates within the Healthcare sector and the Hospital &amp; Healthcare Services industry. Based on the supplied classification, it sits in a segment where listed companies often command very different valuation multiples, making comparisons on profitability and scale especially important.<\/p>\n<p>With a market capitalisation of Rs 32,406.57 crore, the company is one of the larger listed names in its industry, though smaller than several hospital-led peers in the supplied comparison set. In market terms, Dr. Lal Pathlabs Share Price is often tracked through sector valuations, return ratios and relative positioning against other healthcare-service businesses.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Dr_Lal_Pathlabs_Share_Price_on_Univest\"><\/span><strong>Track Dr. Lal Pathlabs Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs (LALPATHLAB) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>Investors can use Univest to track live price moves, technical indicators, valuation ratios and broader market context in one place, while also comparing the stock with sector peers through a more structured workflow.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Dr_Lal_Pathlabs_Share_Price_falling_today\"><\/span><strong>Why is Dr. Lal Pathlabs Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Dr. Lal Pathlabs Share Price was down 2.51% at Rs 1,891.25 versus the previous close of Rs 1,939.95. The supplied data confirms the decline, but it does not establish a company-specific catalyst for today\u2019s move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Dr_Lal_Pathlabs_Share_Price_Today\"><\/span><strong>What is the current Dr. Lal Pathlabs Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The stock stands at Rs 1,891.25 as of the supplied timestamp. It opened at Rs 1,923.45, touched a high of Rs 1,934.80 and moved to an intraday low of Rs 1,876.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Dr_Lal_Pathlabs_stock_fall_today\"><\/span><strong>How much did Dr. Lal Pathlabs stock fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The stock declined by Rs 48.70 in absolute terms and by 2.51% on the day from a previous close of Rs 1,939.95. The previous close was Rs 1,939.95. The stock moved 2.51% lower during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_valuation_ratios_say_about_Dr_Lal_Pathlabs\"><\/span><strong>What do the valuation ratios say about Dr. Lal Pathlabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The stock trades at a P\/E of 60.09 and a P\/B of 12.46. Its P\/E is above the industry median of 47.88 but below the industry average of 103.86, while P\/B is well above benchmark medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Dr_Lal_Pathlabs_compared_with_its_industry\"><\/span><strong>How profitable is Dr. Lal Pathlabs compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Profitability appears strong on the supplied numbers. ROE is 22.37% versus an industry median of 12.82%, while ROCE is 29.56% against a median of 15.7%. The stock belongs to the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_compare_with_Apollo_Hospitals\"><\/span><strong>How does Dr. Lal Pathlabs compare with Apollo Hospitals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;It trades at a P\/E of 60.09 against Apollo Hospitals\u2019 60.97 and a P\/B of 12.46 against 13.15. Its ROCE of 29.56% is higher, while Apollo\u2019s ROE of 23.54% is slightly stronger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_does_Dr_Lal_Pathlabs_belong_to\"><\/span><strong>Which sector does Dr. Lal Pathlabs belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Dr. Lal Pathlabs belongs to the Healthcare sector and the Hospital &amp; Healthcare Services industry. In the supplied same-industry benchmark, the comparison set covers 62 companies. The stock belongs to the Healthcare sector.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Lal Pathlabs Share Price falls to Rs 1,891.25. marking a 2.51% fall today. Market cap stands at Rs 32,406.57 crore.<\/p>\n","protected":false},"author":29,"featured_media":225152,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-225155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["225152"],"rank_math_title":["Dr. Lal Pathlabs Share Price Fall: Price Action View"],"rank_math_description":["Dr. Lal Pathlabs Share Price fell 2.51% to Rs 1,891.25. Read price action, valuation, peer comparison and healthcare sector analysis."],"rank_math_focus_keyword":["Dr. Lal Pathlabs Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Dr_Lal_Pathlabs_LALPATHLAB_Share_Price_Falls_251_Today_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=225155"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225155\/revisions"}],"predecessor-version":[{"id":225156,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225155\/revisions\/225156"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/225152"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=225155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=225155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=225155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}